Pharmaceutical

CLn Skin Care Launches FDA-Cleared Hypochlorous Spray for Sensitive and Irritated Skin Portable, Physician-Recommended Spray Offers Gentle Cleansing and Supports Natural Healing

CLn Skin Care, a leader in dermatologist-developed therapeutic skincare, is proud to announce the launch of its new Hypochlorous Acid…

3 months ago

Global Reach, Local Impact: The Power of SPARK(TM) in 2025

NORTHAMPTON, MA / ACCESS Newswire / September 24, 2025 / Volunteerism is a cornerstone at the Life Science business of…

3 months ago

CS Diagnostics Corp. (OTCQB: CSDX) Accelerates Global Expansion with Key Regulatory Milestones and Record Growth

CHEYENNE, WY / ACCESS Newswire / September 24, 2025 / CS Diagnostics Corp. (OTCQB:CSDX) ("CSDX" or "the Company"), a pioneering…

3 months ago

Ambience Healthcare Launches Real-Time HCC Compliance Validator to Reduce Audit Risk and Strengthen Documentation Integrity

SAN FRANCISCO, CA / ACCESS Newswire / September 24, 2025 / Ambience Healthcare today announced the launch of its HCC…

3 months ago

CS Diagnostics Corp. (OTCQB: CSDX) Accelerates Global Expansion with Key Regulatory Milestones and Record Growth

CHEYENNE, WY / ACCESS Newswire / September 24, 2025 / CS Diagnostics Corp. (OTCQB:CSDX) ("CSDX" or "the Company"), a pioneering…

3 months ago

Medical Care Technologies Inc. Unveils AI Facial Analysis for Early Diabetes Detection

MESA, ARIZONA / ACCESS Newswire / September 24, 2025 / Medical Care Technologies Inc. (OTC PINK:MDCE) announced a breakthrough in…

3 months ago

Ambience Healthcare Launches Real-Time HCC Compliance Validator to Reduce Audit Risk and Strengthen Documentation Integrity

SAN FRANCISCO, CA / ACCESS Newswire / September 24, 2025 / Ambience Healthcare today announced the launch of its HCC…

3 months ago

Medical Care Technologies Inc. Unveils AI Facial Analysis for Early Diabetes Detection

MESA, ARIZONA / ACCESS Newswire / September 24, 2025 / Medical Care Technologies Inc. (OTC PINK:MDCE) announced a breakthrough in…

3 months ago

A Historic Leap Toward Curing Heart Disease: New Study Shows Cavadex Dramatically Reverses Symptoms and Restores Quality of Life in High-Risk Patients

Groundbreaking Observational Study Reveals 88% of Participants Experienced Significant Health Improvements, Offering Unprecedented Hope in the Fight Against the World's…

3 months ago

A Historic Leap Toward Curing Heart Disease: New Study Shows Cavadex Dramatically Reverses Symptoms and Restores Quality of Life in High-Risk Patients

Groundbreaking Observational Study Reveals 88% of Participants Experienced Significant Health Improvements, Offering Unprecedented Hope in the Fight Against the World's…

3 months ago
Show more Posts
Show previous Posts